STOCK-BASED COMPENSATION - RSU, Restricted Stock and Performance Share Activity (Details)	3 Months Ended
	Apr. 30, 2023 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reduction in number of shares available for grant by each RSU or PSU award | shares	2
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	4 years
Beginning vesting term	one year after the date of grant
First RSU Vesting Installments, Nonemployee Directors, Number of Yrs Following Grant Date	the earlier of one year after the date of grant or the date of the Annual Meeting of Stockholders following the year of grant
Non-vested activity [Roll Forward]
Other than options, non-vested number, beginning of period | shares	1,325,000
Other than options, granted number | shares	579,000
Other than options, vested number | shares	157,000
Other than options, forfeited number | shares	21,000
Other than options, non-vested number, end of period | shares	1,726,000
Other than options, non-vested, weighted average grant date fair value, beginning of period | $ / shares	$ 77.33
Other than options, granted, weighted average grant date fair value | $ / shares	83.91
Other than options, vested, weighted average grant date fair value | $ / shares	84.66
Other than options, forfeited, weighted average grant date fair value | $ / shares	79.15
Other than options, non-vested, weighted average grant date fair value, end of period | $ / shares	$ 78.85
Performance Shares (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	3 years
Non-vested activity [Roll Forward]
Other than options, non-vested number, beginning of period | shares	244,000
Other than options, granted number | shares	122,000
Change due to market conditions achieved above target | shares	35,000
Other than options, vested number | shares	102,000
Other than options, forfeited number | shares	0
Other than options, non-vested number, end of period | shares	299,000
Other than options, non-vested, weighted average grant date fair value, beginning of period | $ / shares	$ 84.40
Other than options, granted, weighted average grant date fair value | $ / shares	100.44
Change due to market conditions achieved above target | $ / shares	58.35
Other than options, vested, weighted average grant date fair value | $ / shares	58.35
Other than options, forfeited, weighted average grant date fair value | $ / shares	0
Other than options, non-vested, weighted average grant date fair value, end of period | $ / shares	$ 96.81
Performance Shares (PSUs) [Member] | Performance Share Units (PSUs) granted in 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of Final Number of Shares Based Upon the Company's Total Shareholder Return	50.00%
Percent of Final Number of Shares Based Upon the Company's ROIC	50.00%
Performance Shares (PSUs) [Member] | Performance Share Units (PSUs) granted in 2022 and 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of Final Number of Shares Based Upon the Company's Consolidated Earnings Before Interest and Taxes	50.00%
Percentage of Final Number of Shares Based Upon the Company's Total Shareholder Return	50.00%
Performance Shares (PSUs) [Member] | Performance Share Units (PSUs) granted in 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of Final Number of Shares Based Upon the Company's Absolute Stock Price Growth	50.00%
Percentage of Final Number of Shares Based Upon the Company's Total Shareholder Return	50.00%
Performance Shares (PSUs) [Member] | Monte Carlo Model [Member]
Assumptions used to estimate fair value of stock based awards [Abstract]
Weighted average risk-free interest rate	3.56%
Weighted average Company volatility	58.21%
Expected annual dividends per share | $	$ 0.15
Restriction of Liquidity Discount	7.40%
Non-vested activity [Roll Forward]
Other than options, granted, weighted average grant date fair value | $ / shares	$ 120.42